Literature DB >> 6459154

Beta-hexosaminidase activities and isoenzymes in normal human ovary and ovarian adenocarcinoma.

S K Chatterjee, K Chowdhury, M Bhattacharya, J J Barlow.   

Abstract

Levels and isoenzyme profiles of beta-hexosaminidase were compared in extracts from normal ovarian and ovarian epithelial tumors. The specific activities of beta-hexosaminidase were significantly (P less than 0.001) higher in malignant than in normal ovarian tissues. The enzyme levels of the tumors depended on their degree of differentiation. Well-differentiated tumors had activities in the normal range, while poorly differentiated ones had values higher than the normal mean +/- 2 SD. The moderately and moderately to poorly differentiated tumors had intermediate levels. DEAE-cellulose chromatography was used to resolve the isoenzyme of beta-hexosaminidase. Two major forms, beta-hexosaminidase A and beta-hexosaminidase B, were detected in all the preparations. In one tumor specimen, a component eluting slightly ahead of beta-hexosaminidase A was also detected. For quick separation, a batch-wise procedure using DEAE-cellulose was adapted. Proportions of the isoenzymes A and B separated by batch-wise procedure were similar to those obtained by column chromatography. Heat stability, optimum pH, acid stability and substrate specificity of the beta-hexomsaminidase isoenzymes from ovarian tissues were similar to those from other human sources. Isoenzymes from tumor extracts were more labile to heat and acid pH compared with those from normal source. Slight differences in the affinity for the substrate p-nitrophenyl-beta-N-acetyl-galactosaminidase between the isoenzymes from normal and malignant ovaries were noted.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6459154     DOI: 10.1002/1097-0142(19820101)49:1<128::aid-cncr2820490124>3.0.co;2-t

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  4 in total

1.  Serum beta-N-acetyl hexosaminidase and bile acid levels in patients with benign and malignant biliary obstruction.

Authors:  E Scapa; B H Novis; M Loewenstein; P Thomas; N Zamcheck
Journal:  Dig Dis Sci       Date:  1988-02       Impact factor: 3.199

2.  Activity of lysosomal exoglycosidases in human gliomas.

Authors:  P Wielgat; U Walczuk; S Szajda; M Bień; L Zimnoch; Z Mariak; K Zwierz
Journal:  J Neurooncol       Date:  2006-05-19       Impact factor: 4.130

3.  Aberrant Protein Glycosylation in Brain Cancers, with Emphasis on Glioblastoma.

Authors:  Livia Rosa-Fernandes; Sueli Mieko Oba-Shinjo; Janaina Macedo-da-Silva; Suely Kazue Nagahashi Marie; Giuseppe Palmisano
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

Review 4.  Glycosidases in cancer and invasion.

Authors:  R J Bernacki; M J Niedbala; W Korytnyk
Journal:  Cancer Metastasis Rev       Date:  1985       Impact factor: 9.264

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.